Skip to main content
Top
Published in: Journal of General Internal Medicine 3/2013

01-03-2013 | Original Research

Intentional Non-Adherence to Medications among HIV Positive Alcohol Drinkers: Prospective Study of Interactive Toxicity Beliefs

Authors: Seth C. Kalichman, PhD, Tamar Grebler, BA, Christina M. Amaral, MA, Megan McNerey, MA, Denise White, MA, Moira O. Kalichman, MSW, Chauncey Cherry, MPH, Lisa Eaton, PhD

Published in: Journal of General Internal Medicine | Issue 3/2013

Login to get access

ABSTRACT

BACKGROUND

Antiretroviral therapy (ART) adherence is key to successful treatment of HIV infection and alcohol is a known barrier to adherence. Beyond intoxication, ART adherence is impacted by beliefs that mixing alcohol and medications is toxic.

PURPOSE

To examine prospective relationships of factors contributing to intentional medication non-adherence when drinking.

METHODS

People who both receive ART and drink alcohol (N = 178) were enrolled in a 12-month prospective cohort study that monitored beliefs about the hazards of mixing ART with alcohol (interactive toxicity beliefs), alcohol consumption using electronic daily diaries, ART adherence assessed by both unannounced pill counts and self-report, and chart-abstracted HIV viral load.

RESULTS

Participants who reported skipping or stopping their ART when drinking (N = 90, 51 %) demonstrated significantly poorer ART adherence, were less likely to be viral suppressed, and more likely to have CD4 counts under 200/cc3. Day-level analyses showed that participants who endorsed interactive toxicity beliefs were significantly more likely to miss medications on drinking days.

CONCLUSIONS

Confirming earlier cross-sectional studies, the current findings from a prospective cohort show that a substantial number of people intentionally skip or stop their medications when drinking. Interventions are needed to correct alcohol-related interactive toxicity misinformation and promote adherence among alcohol drinkers.
Literature
1.
go back to reference Parienti JJ, Das-Douglas M, Massari V, et al. Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS One. 2008;3(7):e2783.PubMedCrossRef Parienti JJ, Das-Douglas M, Massari V, et al. Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS One. 2008;3(7):e2783.PubMedCrossRef
2.
go back to reference Kobin AB, Sheth NU. Levels of adherence required for virologic suppression among newer antiretroviral medications. Ann Pharmacother. 2011;45(3):372–9.PubMedCrossRef Kobin AB, Sheth NU. Levels of adherence required for virologic suppression among newer antiretroviral medications. Ann Pharmacother. 2011;45(3):372–9.PubMedCrossRef
3.
go back to reference Hendershot CS, Stoner SA, Pantalone DW, et al. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr. 2009;52(2):180–202.PubMedCrossRef Hendershot CS, Stoner SA, Pantalone DW, et al. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr. 2009;52(2):180–202.PubMedCrossRef
4.
go back to reference Braithwaite RS, Kozal MJ, Chang CC, et al. Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies. AIDS. 2007;21(12):1579–89.PubMedCrossRef Braithwaite RS, Kozal MJ, Chang CC, et al. Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies. AIDS. 2007;21(12):1579–89.PubMedCrossRef
5.
go back to reference Braithwaite RS, McGinnis KA, Conigliaro J, et al. A temporal and dose–response association between alcohol consumption and medication adherence among veterans in care. Alcohol Clin Exp Res. 2005;29(7):1190–7.PubMedCrossRef Braithwaite RS, McGinnis KA, Conigliaro J, et al. A temporal and dose–response association between alcohol consumption and medication adherence among veterans in care. Alcohol Clin Exp Res. 2005;29(7):1190–7.PubMedCrossRef
6.
go back to reference Aloisi MS, Arici C, Balzano R, et al. Behavioral correlates of adherence to antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31(Suppl 3):S145–8.PubMedCrossRef Aloisi MS, Arici C, Balzano R, et al. Behavioral correlates of adherence to antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31(Suppl 3):S145–8.PubMedCrossRef
7.
go back to reference Sankar A, Wunderlich T, Neufeld S, et al. Sero-positive African Americans’ beliefs about alcohol and their impact on anti-retroviral adherence. AIDS Behav. 2007;11(2):195–203.PubMedCrossRef Sankar A, Wunderlich T, Neufeld S, et al. Sero-positive African Americans’ beliefs about alcohol and their impact on anti-retroviral adherence. AIDS Behav. 2007;11(2):195–203.PubMedCrossRef
8.
go back to reference Kalichman SC, Amaral CM, White D, et al. Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS. AIDS Patient Care STDs. 2009;23(6):449–54.PubMedCrossRef Kalichman SC, Amaral CM, White D, et al. Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS. AIDS Patient Care STDs. 2009;23(6):449–54.PubMedCrossRef
9.
go back to reference Neuman MG, Schneider M, Nanau RM, et al. HIV-antiretroviral therapy induced liver, gastrointestinal, and pancreatic injury. Int J Hepatol. 2012;2012:760706.PubMed Neuman MG, Schneider M, Nanau RM, et al. HIV-antiretroviral therapy induced liver, gastrointestinal, and pancreatic injury. Int J Hepatol. 2012;2012:760706.PubMed
10.
go back to reference Price JC, Thio CL. Liver disease in the HIV-infected individual. Clin Gastroenterol Hepatol. 2010;8(12):1002–12.PubMedCrossRef Price JC, Thio CL. Liver disease in the HIV-infected individual. Clin Gastroenterol Hepatol. 2010;8(12):1002–12.PubMedCrossRef
11.
go back to reference Szabo G, Zakhari S. Mechanisms of alcohol-mediated hepatotoxicity in human-immunodeficiency-virus-infected patients. World J Gastroenterol. 2011;17(20):2500–6.PubMedCrossRef Szabo G, Zakhari S. Mechanisms of alcohol-mediated hepatotoxicity in human-immunodeficiency-virus-infected patients. World J Gastroenterol. 2011;17(20):2500–6.PubMedCrossRef
12.
go back to reference Paquette D, Bryant J, de Wit J. Respondent-driven sampling and the recruitment of people with small injecting networks. AIDS Behav. 2012;16(4):890–9.PubMedCrossRef Paquette D, Bryant J, de Wit J. Respondent-driven sampling and the recruitment of people with small injecting networks. AIDS Behav. 2012;16(4):890–9.PubMedCrossRef
13.
go back to reference Gribble JN, Miller HG, Cooley PC, et al. The impact of T-ACASI interviewing on reported drug use among men who have sex with men. Subst Use Misuse. 2000;35(6–8):869–90.PubMedCrossRef Gribble JN, Miller HG, Cooley PC, et al. The impact of T-ACASI interviewing on reported drug use among men who have sex with men. Subst Use Misuse. 2000;35(6–8):869–90.PubMedCrossRef
14.
go back to reference Morrison-Beedy D, Carey MP, Tu X. Accuracy of audio computer-assisted self-interviewing (ACASI) and self-administered questionnaires for the assessment of sexual behavior. AIDS Behav. 2006;10(5):541–52.PubMedCrossRef Morrison-Beedy D, Carey MP, Tu X. Accuracy of audio computer-assisted self-interviewing (ACASI) and self-administered questionnaires for the assessment of sexual behavior. AIDS Behav. 2006;10(5):541–52.PubMedCrossRef
15.
go back to reference Kalichman SC, Rompa D, Cage M. Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS. J Nerv Ment Dis. 2000;188(10):662–70.PubMedCrossRef Kalichman SC, Rompa D, Cage M. Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS. J Nerv Ment Dis. 2000;188(10):662–70.PubMedCrossRef
16.
go back to reference Saunders JB, Aasland OG, Babor TF, et al. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption II. Addictions. 1993;88(6):791–804.CrossRef Saunders JB, Aasland OG, Babor TF, et al. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption II. Addictions. 1993;88(6):791–804.CrossRef
17.
go back to reference Babor T, Higgins-Biddle J, Saunders J, et al. The Alcohol Use Disorders Identification Test: Guidelines for use inprimary Care. 2nd ed. Geneva: World Health Organization; 2001. Babor T, Higgins-Biddle J, Saunders J, et al. The Alcohol Use Disorders Identification Test: Guidelines for use inprimary Care. 2nd ed. Geneva: World Health Organization; 2001.
18.
go back to reference Maisto SA, Conigliaro J, McNeil M, et al. An empirical investigation of the factor structure of the AUDIT. Psychol Assess. 2000;12(3):346–53.PubMedCrossRef Maisto SA, Conigliaro J, McNeil M, et al. An empirical investigation of the factor structure of the AUDIT. Psychol Assess. 2000;12(3):346–53.PubMedCrossRef
19.
go back to reference Altice F, Mostashari F, Friedland G. Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;28:47–58.PubMed Altice F, Mostashari F, Friedland G. Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;28:47–58.PubMed
20.
go back to reference Bangsberg DR, Hecht FM, Charlebois ED, et al. Comparing objective measures of adherence to HIV antiretroviral therapy: electronic medication monitors and unannounced pill counts. AIDS Behav. 2001;5:275–81.CrossRef Bangsberg DR, Hecht FM, Charlebois ED, et al. Comparing objective measures of adherence to HIV antiretroviral therapy: electronic medication monitors and unannounced pill counts. AIDS Behav. 2001;5:275–81.CrossRef
21.
go back to reference Kalichman SC, Amaral CM, Cherry C, et al. Monitoring Antiretroviral adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validity. HIV Clin Trials. 2008;9:298–308.PubMedCrossRef Kalichman SC, Amaral CM, Cherry C, et al. Monitoring Antiretroviral adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validity. HIV Clin Trials. 2008;9:298–308.PubMedCrossRef
22.
go back to reference Kalichman SC, Amaral CM, Stearns HL, et al. Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. J Gen Intern Med. 2007;22:1003–6.PubMedCrossRef Kalichman SC, Amaral CM, Stearns HL, et al. Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. J Gen Intern Med. 2007;22:1003–6.PubMedCrossRef
23.
go back to reference Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12(3):255–66.PubMedCrossRef Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12(3):255–66.PubMedCrossRef
24.
go back to reference Ickovics JR, Meisler AW. Adherence in AIDS clinical trials: a framework for clinical research and clinical care. J Clin Epidemiol. 1997;50(4):385–91.PubMedCrossRef Ickovics JR, Meisler AW. Adherence in AIDS clinical trials: a framework for clinical research and clinical care. J Clin Epidemiol. 1997;50(4):385–91.PubMedCrossRef
25.
go back to reference Simoni J, Kurth AE, Pearson C, et al. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10:227–331.PubMedCrossRef Simoni J, Kurth AE, Pearson C, et al. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10:227–331.PubMedCrossRef
26.
go back to reference Bernhardt JM, Usdan S, Mays D, et al. Alcohol assessment among college students using wireless mobile technology. J Stud Alcohol Drugs. 2009;70(5):771–5.PubMed Bernhardt JM, Usdan S, Mays D, et al. Alcohol assessment among college students using wireless mobile technology. J Stud Alcohol Drugs. 2009;70(5):771–5.PubMed
27.
go back to reference McAuliffe TL, DiFranceisco W, Reed BR. Low numeracy predicts reduced accuracy of retrospective reports of frequency of sexual behavior. AIDS Behav. 2010;14(6):1320–9.PubMedCrossRef McAuliffe TL, DiFranceisco W, Reed BR. Low numeracy predicts reduced accuracy of retrospective reports of frequency of sexual behavior. AIDS Behav. 2010;14(6):1320–9.PubMedCrossRef
28.
go back to reference Bangsberg D, Kroetz DL, Deeks SG. Adherence-resistance relationships to combination HIV antiretroviral therapy. Curr HIV/AIDS Rep. 2007;4:65–72.PubMedCrossRef Bangsberg D, Kroetz DL, Deeks SG. Adherence-resistance relationships to combination HIV antiretroviral therapy. Curr HIV/AIDS Rep. 2007;4:65–72.PubMedCrossRef
29.
go back to reference Li JZ, Paredes R, Ribaudo H, et al. Relationship between Minority NNRTI resistance mutations, adherence, and the risk of virologic failure. AIDS. 2011;26:185–92.CrossRef Li JZ, Paredes R, Ribaudo H, et al. Relationship between Minority NNRTI resistance mutations, adherence, and the risk of virologic failure. AIDS. 2011;26:185–92.CrossRef
30.
go back to reference Bangsberg DR, Deeks SG. Is average adherence to HIV antiretroviral therapy enough? J Gen Intern Med. 2002;17(10):812–3.PubMedCrossRef Bangsberg DR, Deeks SG. Is average adherence to HIV antiretroviral therapy enough? J Gen Intern Med. 2002;17(10):812–3.PubMedCrossRef
Metadata
Title
Intentional Non-Adherence to Medications among HIV Positive Alcohol Drinkers: Prospective Study of Interactive Toxicity Beliefs
Authors
Seth C. Kalichman, PhD
Tamar Grebler, BA
Christina M. Amaral, MA
Megan McNerey, MA
Denise White, MA
Moira O. Kalichman, MSW
Chauncey Cherry, MPH
Lisa Eaton, PhD
Publication date
01-03-2013
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 3/2013
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-012-2231-1

Other articles of this Issue 3/2013

Journal of General Internal Medicine 3/2013 Go to the issue